Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasting Mimicking Diet in Ulcerative Colitis
NCT04505410Phase 3Completed
- Sponsor
- University of Miami
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in ulcerative colitis (UC) (2 arms), sponsored by University of Miami. Primary endpoint: Clinical Response based on Simple Clinical Colitis Activity Index at 8 weeks. Started Sep 2020; status: completed.
02
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04505410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505410.